SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-282658
Filing Date
2022-11-10
Accepted
2022-11-10 16:25:06
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d237140d10q.htm   iXBRL 10-Q 1337582
2 EX-10.1 d237140dex101.htm EX-10.1 31674
3 EX-31.1 d237140dex311.htm EX-31.1 6748
4 EX-31.2 d237140dex312.htm EX-31.2 6739
5 EX-32.1 d237140dex321.htm EX-32.1 3315
6 EX-32.2 d237140dex322.htm EX-32.2 3306
  Complete submission text file 0001193125-22-282658.txt   5418068

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA vinc-20220930.xsd EX-101.SCH 33094
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vinc-20220930_cal.xml EX-101.CAL 32611
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vinc-20220930_def.xml EX-101.DEF 185708
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20220930_lab.xml EX-101.LAB 319541
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20220930_pre.xml EX-101.PRE 283446
60 EXTRACTED XBRL INSTANCE DOCUMENT d237140d10q_htm.xml XML 824115
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39244 | Film No.: 221377656
SIC: 2834 Pharmaceutical Preparations